Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D016861:Cyclooxygenase Inhibitors; D011464:Epoprostenol / Q000096:biosynthesis*; D005122:Exudates and Transudates / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D007249:Inflammation / Q000378:metabolism; D007509:Irritants; D016859:Lipoxygenase Inhibitors; D008297:Male; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000096:biosynthesis*; D051381:Rats
D000893:Anti-Inflammatory Agents; D016861:Cyclooxygenase Inhibitors; D007509:Irritants; D016859:Lipoxygenase Inhibitors; D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol